Mineralys Therapeutics, Inc.

NASDAQ
MLYS
Stock
Yield per half year: +39.57%
Dividend yield: 0%
Sector: Healthcare

Reporting Mineralys Therapeutics, Inc.

Capitalization

2020 2021 2022 2023 2024 LTM Average for 5 years CAGR 5
Capitalization, bln $
0.5098 0.5234 0.5098 0.00
Net profit, bln $
-0.0034 -0.0194 -0.0298 -0.0719 -0.1778 -0.1778 -0.0605 120.64
EV, bln $
0.0031 -0.0106 -0.0877 0.2619 0.4834 0.4834 0.1300 174.53
EBIT, bln $
-0.0029 -0.0187 -0.0315 -0.0848 -0.0848 -0.0345 132.54
EBITDA, bln $
-0.0033 -0.0194 -0.0315 -0.0847 -0.1778 -0.1778 -0.0633 121.96
OIBDA $
-0.0025 -0.018 -0.0332 -0.0974 -0.1924 -0.1924 -0.0687 138.37
Book value, bln $
-0.0036 -0.0229 -0.0523 0.2412 0.1913 0.1913 0.0707 -321.35
FCF, bln $
-0.0025 -0.0146 -0.0292 -0.0812 -0.1664 -0.1664 -0.0588 131.55
Operating Cash Flow, bln $
-0.0025 -0.0146 -0.0292 -0.0812 -0.1663 -0.1663 -0.0588 131.52
Operating profit, bln $
-0.0029 -0.0187 -0.0315 -0.0847 -0.1924 -0.1924 -0.0660 131.40
Operating expenses, bln $
0.0029 0.0187 0.0315 0.0847 0.1924 0.1924 0.0660 131.40
CAPEX, bln $
0.0001 0.0001 0.0001 0.00


Balance sheet

2020 2021 2022 2023 2024 LTM Average for 5 years CAGR 5
Cash, bln $
0.0014 0.0106 0.0877 0.0493 0.1141 0.1141 0.0526 141.12
Short-Term Investments $
0.0224 0.1873 0.0841 0.0841 0.0979 55.42
Long-Term Investments $
0.0025 0.0025 0.00
Total Current Assets $
0.0015 0.0111 0.1101 0.2491 0.2054 0.2054 0.1154 167.49
Net assets, bln $
0.0015 0.0111 0.1101 0.2753 0.1101 0.0995 268.07
Assets, bln $
0.0015 0.0111 0.1144 0.2516 0.2059 0.2059 0.1169 167.62
Short-Term Debt $
0.0045 0.0045 0.00
Liabilities, bln $
0.0051 0.0341 0.1667 0.0105 0.0146 0.0146 0.0462 23.41
Net debt, bln $
0.0031 -0.0106 -0.0877 -0.0493 -0.1141 -0.1141 -0.0517 -305.68
Debt, bln $
0.0045 0.0045 0.00
Interest Income $
0.0017 0.0104 0.0060 147.34
Interest Expense, bln $
0.000115 0.0000 0.0017 0.0009 284.48
Net interest income, bln $
-0.000115 0.0000 0.0017 0.0104 0.0104 0.0040 -548.86
Amortization, bln $
0 0 0.000228 0.000168 0.000168 0.0002 -14.16


Share

2020 2021 2022 2023 2024 2025 LTM Average for 5 years CAGR 5
EPS -0.0877 -0.4969 -0.7294 -1.99 -3.66 -3.66 -1.3928 110.91
Share price 8.6 12.31 14.32 14.32 11.74 18.53
Number of shares, mln 39.06 39.06 40.86 36.19 48.54 48.54 40.74 4.44
FCF/share -0.0631 -0.3728 -0.7152 -2.24 -3.43 -3.43 -1.3642 122.36


Efficiency

2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
ROE, % 95.25 146.35 79.26 -76.13 -82.24 -82.24 17.60 32.50 -197.11
ROA, % -230.55 -307.79 -47.46 -39.28 -77.72 -77.72 5.71 -140.5600 -19.54
ROS, % 0 0 0 0 13.36
ROCE, % 81.82 -308.43 -29.59 -35.17 -44.35 -44.35 29.73 -67.1440 -188.47
EBIT margin 0 0 18.53
EBITDA margin 0 0 26.10
Net margin 0 13.36
Operational efficiency, % 0 0 0 0 16.64
FCF yield, % -15.92 -15.9200 0.00


Coefficients

2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
P/E
-7.09 69.12 -7.0900 0.00
P/BV
1.29 3.12 3.12 8.87 2.21 55.52
P/FCF
-17.92 -6.45 -3.15 -3.15 8.97 -9.1733 -43.98
E/P
-0.141 -0.1374 -0.3397 -0.3397 0.03 -0.2060 34.06
EV/EBIT
-0.5251 0.2834 2.79 -3.09 -2.9 -5.7 -5.7 88.11 -1.7233 -282.26
EV/EBITDA
-0.9336 0.5668 2.79 -3.09 -2.72 -2.72 53.63 -0.6774 23.85
EV/S
0 0 0 0 8.36
EV/FCF
-1.25 0.7289 3 -3.23 -2.91 -2.91 -2.91 21.77 -1.0642 -231.90
Debt/EBITDA
-1.53 0 0 0 0 2.61 -1.5300 0.00
Netdebt/Ebitda
-1.05 0.5668 2.79 0.5824 0.6418 0.6418 0.6418 0.49 1.04 2.52
Debt/Ratio
3.03 0 0 0 0 0.24 3.03 0.00
Debt/Equity
-1.25 0 0 0.0766 0.0766 2.82 -0.5867 -124.75
Debt/Net Income
-1.31 0 0 0 0 10.75 -1.3100 0.00
PEG
0 0 -67.37
Beta
-1.85 0.5358 0.0532 0.0532 -0.03 -0.4203 -130.64
Altman Index
4.29 0.7175 1.22 1.22 12.59 2.08 -34.24


Dividends

2019 2020 LTM Industry average Average for 5 years CAGR 5
Div. payout, bln
0.0038 0.0038 0.0038 0.00
Dividend
0
Dividend yield, %
0 1.71
Dividends / profit, %
-111.79 0 155.02 -111.7900 0.00


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Other

2023 2024 CAGR 5
Staff, people
12 28 52.75